Memantine and cognitive dysfunction in bipolar disorder
Phase of Trial: Phase IV
Latest Information Update: 10 May 2017
At a glance
- Drugs Memantine (Primary)
- Indications Bipolar disorders; Cognition disorders
- Focus Therapeutic Use
- 26 Mar 2012 Actual patient number (47) added as reported by ClinicalTrials.gov.
- 26 Mar 2012 Actual end date Jun 2010 added as reported by ClinicalTrials.gov.
- 26 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History